TNFSF10 and cancer: Invariably, this revealed that CDK9i exerted potent sensitization of these different cancer cell lines to TRAIL-induced apoptosis and that TRAIL–CDK9i combination treatment was substantially more effective at killing these cells than their respective currently applied stand-of-care therapy (Fig. 1e-g and Supplementary Fig. 1f).